About us
MISSION
We strive to bring safe and reliable treatment modalities to support patients with unmet medical need by transforming the promise of modern science with the power of our know-how and experience into products and technologies that enhance, improve, or even save lives.
There is the potential, currently, to implement a new generation of inhibitors in clinical practice with the aim of achieving the desired therapeutic effect without side effects. It’s why Selecta Biotech was founded.
LEADERSHIP
FILIP RÁZGA
Dr Razga has 20+ years of professional experience in oncology with a biotechnology focus in the last decade.
Veronika Némethová
Dr Nemethova coordinates the development and preclinical studies of therapeutic leads for treatment of multiple diseases.
LEGAL & BUSINESS
MIROSLAV IVANOVIČ
Dr Ivanovic represents Selecta in the field of intellectual property rights, commercial, and medical law.
TIBOR ČEMICKÝ
Mr Cemicky leads strategic partnerships at Selecta, focusing on licensing and collaborations to expand the company’s oligonucleotide therapies into new markets.